Prostatis Group’s First Trust Capital Strength ETF FTCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-10,912
Closed -$806K – 132
2023
Q3
$806K Buy
10,912
+523
+5% +$39.6K 0.39% 52
2023
Q2
$780K Buy
+10,389
New +$761K 0.36% 60
2023
Q1
– Sell
-11,175
Closed -$838K – 105
2022
Q4
$838K Sell
11,175
-30,738
-73% -$2.27M 0.51% 47
2022
Q3
$2.78M Buy
+41,913
New +$3.01M 3.21% 9

Other funds holding FTCS

Prostatis Group's FTCS Position: Q4 2023 in Review

Prostatis Group sold out of First Trust Capital Strength ETF (FTCS) in Q4 2023, closing a stake of 10,912 shares — an estimated $806K sold.

Prostatis Group first reported a position in FTCS in Q3 2022 and held it in 4 quarters. The position peaked at $2.78M in Q3 2022. 463 funds tracked by Wall St. Rank hold FTCS as of Q4 2023.

  • Prostatis Group reported no remaining First Trust Capital Strength ETF position as of Q4 2023 after selling out during the quarter.
  • Prostatis Group sold 10,912 First Trust Capital Strength ETF shares in Q4 2023, an estimated $806K.
  • Prostatis Group first reported a position in First Trust Capital Strength ETF in Q3 2022 and held it in 4 quarters.
  • Prostatis Group's First Trust Capital Strength ETF position peaked at $2.78M in Q3 2022.
  • 463 funds tracked by Wall St. Rank held First Trust Capital Strength ETF as of Q4 2023.

Based on Prostatis Group's 13F filing for Q4 2023, filed 21 Mar 2025.